Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients
- Conditions
- Multiple TraumaWounds and InjuriesDisorder of Fluid Balance
- Registration Number
- NCT01270854
- Lead Sponsor
- University of California, Davis
- Brief Summary
The purpose of this study is to determine whether an intravenous salt solution called "Plasmalyte" causes less abnormality of the body's acid levels than a solution called "Normal Saline."
- Detailed Description
Electrolyte-containing intravenous fluids are routinely administered to patients in the first few hours after acute traumatic injury. Although Normal Saline (0.9% sodium chloride) is commonly used in this setting, it causes a hyperchloremic acidosis that may exacerbate metabolic derangements that occur after acute injury. Plasmalyte A is a solution that more closely matches physiologic electrolyte levels. In this study, we will evaluate whether Plasmalyte A results in less disturbance of the base deficit 24 hours following traumatic injury than does Normal Saline.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 46
-
Triaged upon arrival to the hospital as severely injured
-
At least 18 years of age
-
Meets at least one of the following criteria:
- Intubated or likely to become intubated within 60 minutes of arrival at the hospital
- Likely to need an operation within 60 minutes of arrival
- Received or likely to receive a blood transfusion within 60 minutes of arrival
- Greater than 60 minutes since arrival at the hospital
- Death likely within 48 hours
- Transfer from another hospital
- Pre-existing renal failure requiring dialysis
- Pregnancy
- Prisoner status
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in the base deficit 24 hours after randomization Base deficit at 24 hours after randomization minus the base deficit at randomization
- Secondary Outcome Measures
Name Time Method Mortality Hospital discharge
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of California, Davis, Medical Center
🇺🇸Sacramento, California, United States
University of California, Davis, Medical Center🇺🇸Sacramento, California, United States